16.88
-1.23%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Shaanxi Meibang Pharmaceutical Group Co
Its shares trade on Shanghai under the ticker 605033.SS. It has been listed since 16 September 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥912.0m and net income of CN¥48.7m. At that date it held total assets of CN¥2.07bn and shareholders' equity of CN¥1.15bn.
Shaanxi Meibang Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pesticide preparations. The company is headquartered in Xi'An, Shaanxi. The company went IPO on 2021-09-16. The firm's products mainly include fungicides and pesticides. The fungicides include 80% dimethylmorpholine water dispersible granules, 27% chunleimycin bromonitrile wettable powder, 72% pyrazole ether ester combined water dispersible granules, 22% chunleimycin chlorobromoisocyanuric acid wettable powder, etc. The insecticides include 21% abamectin benzoate fenitrile suspension, 22% thiamethoxam beta cypermethrin suspension, 45% biphenyl hydrazide ethiconazole suspension, 20% fenitrile bifenthrin suspension, etc.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 16 Sept 2021
- Employees
- 1,025
- Website
- meibang.cn ↗
Leadership
Pay as last reported
- Mr. Shaowu ZhangChairman of the BoardCN¥800,000
- Ms. Meixi HeChief Financial OfficerCN¥380,000
- Mr. Tong ZhangGeneral Manager, DirectorCN¥600,000
- Ms. Lijuan HanDeputy General Manager, DirectorCN¥344,000
- Mr. Mingyu QiaoDeputy General ManagerCN¥465,000
- Ms. Aixiang ZhaoSecretary of the BoardCN¥289,000
- Mr. Xiaolong FanDirectorCN¥482,000
- Mr. Fei ZhangDirector
- Ms. Qiufang ZhangDirectorCN¥500,000
- Mr. Hao FengIndependent Director
- Mr. Nan WangIndependent Director
- Mr. He YanIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Shaanxi Meibang Pharmaceutical Group employs 1025 employees in Xi'an, China.
- The company produces 80% dimethylmorpholine water dispersible granules for fungicides.
- Shaanxi Meibang offers 21% abamectin benzoate fenitrile suspension insecticide products.
Weaknesses
- The company's business is limited to pesticide preparations in the Chemicals sector.
- Shaanxi Meibang's products include 27% chunleimycin bromonitrile wettable powder for fungicides.
- The firm's insecticides feature 45% biphenyl hydrazide ethiconazole suspension.
Opportunities
- Shaanxi Meibang can expand its fungicide line with 72% pyrazole ether ester combined water dispersible granules.
- The company may increase sales of 22% chunleimycin chlorobromoisocyanuric acid wettable powder.
- Shaanxi Meibang could target new markets for 20% fenitrile bifenthrin suspension insecticides.
Threats
- Shaanxi Meibang faces competition from other Chemicals sector companies in China.
- The company's reliance on pesticide preparations may limit growth in the Materials sector.
- Shaanxi Meibang must comply with Chinese regulations for pesticide production.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.